Results 251 to 260 of about 651,238 (350)
Comparative single-cell landscape of immune cells in human livers affected HBV and non-viral cirrhosis. [PDF]
Bai Q +11 more
europepmc +1 more source
Changing Pattern of HDV Infection in Italy Over 40 Years; the Current Scenario and the Impending Challenge. [PDF]
Caviglia GP, Stroffolini T.
europepmc +1 more source
Mendelian randomization study finds no causal link between inflammatory bowel disease and cirrhosis. [PDF]
An J +8 more
europepmc +1 more source
What's New? Oncolytic viruses are a promising immunotherapeutic approach against many malignancies. However, it is unclear whether repeated doses have improved therapeutic value or may trigger greater side effects, especially in patients with hepatocellular carcinoma whose liver is chronically damaged.
Karen J. Scott +10 more
wiley +1 more source
The Effects of <i>Helicobacter pylori</i> on the Treatment Outcomes of Peptic Ulcer in Patients with Liver Cirrhosis: A Systematic Review and Network Meta-Analysis. [PDF]
Zhang L, Lin J, Li X.
europepmc +1 more source
Abstract Gastric signet ring cell carcinoma (GSRCC) is a special type of gastric cancer common in young women. Diffuse gastric cancer (DGC) begins with intramucosal lesions comprising differentiated GSRCC cells. Genetically, GSRCC and DGC are clonally identical, with their morphology influenced by extracellular Wnt signaling.
Qian Wang +5 more
wiley +1 more source
Early Prediction of Hepatic Decompensation in Cirrhosis Using Optimised XGBoost Models at the Initial Outpatient Hepatology Visit. [PDF]
Grubert Van Iderstine M +7 more
europepmc +1 more source
Spatial multi‐omics defines a DLL4–NOTCH3–driven capillary–mCAF axis orchestrating fibrotic remodeling and immune exclusion in hepatocellular carcinoma tumor cores, conferring immune checkpoint blockade resistance. Targeting stromal NOTCH3 disrupts this pro‐fibrotic niche, enhances T cell infiltration, and synergizes with anti‐PD‐1 therapy ...
Fansen Ji +18 more
wiley +1 more source

